Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 589 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SIGNAL Clear all

Conditions: Multiple Sclerosis
Interventions: Neubie; Device
Lead sponsor: CommonSpirit Health; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Littleton, Colorado

Conditions: Lung Cancer
Interventions: Binimetinib, Palbociclib; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Glioma
Interventions: ABY-029; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Preschool Child, Executive Function (Cognition)
Interventions: Motor Synchrony Games (MSG); Behavioral
Lead sponsor: Appalachian State University; Other
Eligibility: 2 Years to 5 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boone, North Carolina

Conditions: Healthy Volunteers
Interventions: Peripheral intravenous analysis (PIVA) algorithm; Device
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Myocardial Perfusion Imaging, Magnetic Resonance Imaging
Interventions: Gadavist 15Ml Solution for Injection; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: PIK3CA Mutations, Advanced Solid Tumors, Adult, Endometrial Cancer, HR Positive/HER-2 Negative Breast Cancer, HER2-low Breast Cancer
Interventions: CGT6297; Drug
Lead sponsor: Cogent Biosciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 12
States / cities: Scottsdale, Arizona • Los Angeles, California • Palo Alto, California + 9 more

Conditions: Osteoarthritis
Interventions: RS-4i Plus; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 89 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Orange, California

Conditions: COPD, Weaning Failure
Interventions: Functional neuromuscular electrical stimulation; Device
Lead sponsor: Edward Hines Jr. VA Hospital; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2022
U.S. locations: 2
States / cities: Hines, Illinois • Hinsdale, Illinois

Conditions: Alopecia Areata
Interventions: bempikibart (ADX-914); Drug
Lead sponsor: Q32 Bio Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 28
States / cities: Scottsdale, Arizona • Fayetteville, Arkansas • Hot Springs, Arkansas + 24 more

Conditions: Otitis Media Recurrent, Middle Ear Infection, Ear Infection
Interventions: Advanced Ultrasound Otoscope; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 0 Years to 12 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Volunteer, Attention Deficit Hyperactivity Disorder
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hearing Loss, Cochlear
Interventions: Hearing Aid Noise Reduction - Off, Hearing Aid Noise Reduction - Low, Hearing Aid Noise Reduction - High, Negative SNR, Zero signal-to-noise ratio, Positive SNR; Device · Other
Lead sponsor: Purdue University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Osteoarthritis, Knee
Interventions: Orthofix Physio-Stim Model 3315OA; Device
Lead sponsor: Orthofix Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Baltimore, Maryland • Cleveland, Ohio

Conditions: Healthy Aging
Interventions: Nicotine patch, oral mecamylamine, placebo; Drug
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 75 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Oral Squamous Cell Carcinoma (OSCC)
Interventions: Olaparib; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Lymphoma
Interventions: rituximab, clofarabine, DNA methylation analysis, gene expression analysis, microarray analysis, polymerase chain reaction, high performance liquid chromatography, laboratory biomarker analysis; Biological · Drug · Genetic + 1 more
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 89 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Respiratory Distress Syndrome, Newborn, Bronchopulmonary Dysplasia
Interventions: Noninvasive neurally adjusted ventilatory assist (NIV NAVA), Nasal intermittent positive pressure ventilation (NIPPV); Other
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: Up to 12 Months
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Speech Sound Disorder
Interventions: Visual-acoustic biofeedback, Ultrasound biofeedback; Behavioral
Lead sponsor: New York University; Other
Eligibility: 9 Years to 15 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Bloomfield, New Jersey • New York, New York • Syracuse, New York

Conditions: Cranial Neurosurgery
Interventions: Medtronic LINQII; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Alcohol Use Disorder
Interventions: Cervical transcutaneous vagus nerve stimulation (active comparator), Cervical transcutaneous vagus nerve stimulation (sham comparator); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 65 Years · Male only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Arrhythmia, Cardiac
Interventions: recorded patients; Other
Lead sponsor: NewPace Ltd; Industry
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Atlantis, Florida

Conditions: Bulimia Nervosa, Feeding and Eating Disorders, Mental Disorders
Interventions: Real fNIRS Neurofeedback, Sham-Control fNIRS Neurofeedback, SmartPhone Intervention; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Equipment and Supplies
Interventions: X-Trodes acquisition system; Device
Lead sponsor: B-Cube; Other
Eligibility: 21 Years and older
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Impact of Direct Current Electrical Stimulation on Spasticity Levels and Functional Muscle Use in MS

Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

A Microdose Evaluation Study of ABY-029 in Recurrent Glioma

Do Motor Synchrony Games Improve Self Regulation?

Healthy Volunteer Study to Evaluate the Impact of Various Common Interventions on Venous Pressure Signal Captured by PIVA

Dotarem Evaluation for Myocardial Perfusion CMR

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Patient Observational Pain and Activity Survey (POPAS) Study Using RS-4i Sequential Stimulator With Intersperse Technology in Axial Spine and Peripheral Joint Pain

VentFree: A Novel Abdominal Stimulator to Assist With Ventilator Weaning

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Utility of Advanced Ultrasound Otoscope In The Diagnosis of AOM

PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids

Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee

The Nicotinic Cholinergic System and Cognitive Aging

A Dye for the Detection of Cancer of the Tongue and Mouth

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Work of Breathing During Non-invasive Ventilation in Premature Neonates

Delineation of Sensorimotor Subtypes Underlying Residual Speech Errors

A Study Of Subscalp Placement Of The LINQII Device

Non-invasive Vagal Nerve Stimulation in Alcohol Use Disorder

Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development

Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa

Evaluation of Accuracy and Consistency of the X-Trodes System